Ligand Pharmaceuticals
LGND
#3601
Rank
NZ$6.29 B
Marketcap
NZ$320.01
Share price
-1.93%
Change (1 day)
52.41%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$1.64 Billion

According to Ligand Pharmaceuticals's latest financial reports the company has NZ$1.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Ligand Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$1.47 B32.86%
2023-12-31$NZ$1.10 B17.77%
2022-12-31$NZ$0.94 B-21.72%
2021-12-31$NZ$1.20 B22.26%
2020-12-31$NZ$0.98 B-13.68%
2019-12-31$NZ$1.13 B36.23%
2018-12-31$NZ$0.83 B41.86%
2017-12-31$NZ$0.58 B10.1%
2016-12-31$NZ$0.53 B32.33%
2015-12-31$NZ$0.40 B1198.77%
2014-12-31$NZ$31.15 M-48.4%
2013-12-31$NZ$60.37 M87.53%
2012-12-31$NZ$32.19 M206.99%
2011-12-31$NZ$10.48 M-266.86%
2010-12-31$-NZ$6.29 Million-221.93%
2009-12-31$NZ$5.15 M-128.86%
2008-12-31$-NZ$17.87 Million-146.99%
2007-12-31$NZ$38 M-2.1%
2006-12-31$NZ$38.82 M-124.03%
2005-12-31$-NZ$0.17 Billion53.05%
2004-12-31$-NZ$0.11 Billion82.71%
2003-12-31$-NZ$57.78 Million-140.85%
2002-12-31$NZ$0.14 B-201.47%
2001-12-31$-NZ$0.14 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
NZ$16.65 B 912.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ$46.39 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.65 B 2,128.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$89.85 B 5,362.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.14 B 9,697.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B 2,410.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 1,857.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$12.48 B 659.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.22 B 8,243.45%๐Ÿ‡บ๐Ÿ‡ธ USA